EXTH-43. GENERATION OF A B-CELL-BASED VACCINE FOR THE TREATMENT OF GLIOBLASTOMA

Immunotherapy has revolutionized the treatment of many tumors. However, most glioblastoma (GBM) patients have not, so far, benefited from such successes. With the goal of exploring ways to boost anti-GBM immunity, we developed a B-cell-based vaccine (B(Vax)) that consists of 4-1BBL(+) B cells activa...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Neuro Oncol
Main Authors: Lee Chang, Catalina, Miska, Jason, Hou, David, Rashidi, Aida, Zhang, Peng, Burga, Rachel, Torres, Ignacio Jusue, Xiao, Ting, Arrieta, Victor, Zhang, Daniel, Lopez-Rosas, Aurora, Han, Yu, Sonabend, Adam, Horbinski, Craig, Stupp, Roger, Balyasnikova, Irina, Lesniak, Maciej
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2020
Teme:
Preclinical Experimental Therapeutics
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651425/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.397
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki